Close
0
Inquiry Basket
Hot Products

GlycoErase™ ALG6 Knockout KD Cell Line

CAT#: GLJF-0425-JF645

Datasheet Request COA
Overview
Description
The ALG6 knockout KD cell line, derived from an extra-cranial rhabdoid tumor, is effective for exploring N-glycosylation initiation in this pediatric sarcoma. ALG6 deficient, it impairs early N-glycosylation, potentially causing protein misfolding. Researchers employ it to study N-glycosylation disorder's roles in rhabdoid cancer cell proliferation, migration, drug response, and to develop pathway-targeted drugs for this aggressive disease.
Product Type
KO Cell Lines
Species
Human
Cell Morphology
Epithelial-like, adherent
Passage Ratio
1:2~1:4
Cell Line
KD cell line
Primary Disease
Rhabdoid cancer
Lineage
Soft Tissue
Lineage Subtype
Rhabdoid cancer
Specification
Cell Viability
>90%
Sterility Test
The sterility test indicated an absence of microbial growth.
Identity Test
STR identification
Mycoplasma Test
Negative
Virus Test
Negative for HIV, HBV and HCV.
Genetic Stability Testing
We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation
PCR, Sanger Sequencing
Culture Medium
F-12 & FBS & Penicillin/Streptomycin
Application
Functional assay
Size
1 M cells/vial*2
Product Format
Frozen
Shipping
Dry ice
Availability Status
Made to order
Handling Notes
Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer
This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target Information
Target
ALG6
Full Name
ALG6 alpha-1,3-glucosyltransferase
Alternative Name
CDG1C
Location
1p31.3
Gene ID
Summary
Catalyzes the first glucose addition to the lipid-linked oligosaccharide precursor in N-linked glycosylation; a critical early step in this essential protein modification process.
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.